c.-2265C→T | Hong Kong | Shanghai | TOH,p Value | Combined analysis‡ | ||||||||||
Cases (%) | Controls (%) | p Value* | OR (95% CI)* | Cases (%) | Controls (%) | p Value† | OR 95% CI)† | p Value | OR (95% CI) | |||||
All participants§ | ||||||||||||||
n | 368 | 375 | 1109 | 1185 | ||||||||||
CC | 143 (38.9) | 109 (29.1) | 1.00 (RV) | 469 (42.3) | 457 (38.6) | 1.00 (RV) | 1.00 (RV) | |||||||
CT/TT | 225 (61.1) | 266 (70.9) | 0.005 | 0.64 (0.47 to 0.88) | 640 (57.7) | 728 (61.4) | 0.054 | 0.85 (0.71 to 1.00) | 0.11 | 0.003 | 0.80 (0.69 to 0.93) | |||
HWE p value¶ | 0.23 | 0.22 | 0.07 | 0.55 | ||||||||||
Participants without a family history of breast cancer | ||||||||||||||
n | 333 | 363 | 1070 | 1156 | ||||||||||
CC | 129 (38.7) | 107 (29.5) | 1.00 (RV) | 459 (42.9) | 442 (38.2) | 1.00 (RV) | 1.00 (RV) | |||||||
CT/TT | 204 (61.3) | 256 (70.5) | 0.01 | 0.66 (0.48 to 0.91) | 611 (57.1) | 714 (61.8) | 0.019 | 0.81 (0.69 to 0.97) | 0.23 | 0.001 | 0.78 (0.68 to 0.91) | |||
Participants ⩾45 years at first diagnosis and without a family history of breast cancer | ||||||||||||||
n | 166 | 166 | 637 | 678 | ||||||||||
CC | 71 (42.8) | 46 (27.7) | 1.00 (RV) | 281 (44.1) | 265 (39.1) | 1.00 (RV) | 1.00 (RV) | |||||||
CT/TT | 95 (57.2) | 120 (72.3) | 0.006 | 0.51 (0.32 to 0.81) | 356 (55.9) | 413 (60.9) | 0.039 | 0.79 (0.63 to 0.99) | 0.08 | 0.004 | 0.75 (0.61 to 0.91) |
HWE, Hardy–Weinberg equilibrium; RV, reference value; TOH, test of heterogeneity.
*p Values were obtained by χ2 square test, df = 1.
†Logistic regression analysis adjusted for age, education, body mass index, waist to hip ratio, physical activity, menopausal status, age at menarche and age at first live birth.
‡Combined analysis was performed using Mantel–Hanzel test.
§Overall cases and control participants successfully genotyped.
¶p Values for HWE were calculated by χ2 square test, df = 1.